Stockreport

Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025 [Yahoo! Finance]

Biodexa Pharmaceuticals plc - American Depositary Shares  (BDRX) 
PDF at CGA – IGC Conference on October 11, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company devel [Read more]